Cargando…

The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis

Blast crisis (BC) is an outcome that arises during the treatment process of chronic myeloid leukemia (CML), which is possibly attained by the dysregulation of the Notch and Ikaros signaling pathways, BCR-ABL translocation, redox, and inflammatory factors. This study demonstrated that biotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Vivek, Singh, Ranjana, Mahdi, Abbas Ali, Tripathi, Anil Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262277/
https://www.ncbi.nlm.nih.gov/pubmed/35815090
http://dx.doi.org/10.25122/jml-2021-0230
_version_ 1784742458964312064
author Singh, Vivek
Singh, Ranjana
Mahdi, Abbas Ali
Tripathi, Anil Kumar
author_facet Singh, Vivek
Singh, Ranjana
Mahdi, Abbas Ali
Tripathi, Anil Kumar
author_sort Singh, Vivek
collection PubMed
description Blast crisis (BC) is an outcome that arises during the treatment process of chronic myeloid leukemia (CML), which is possibly attained by the dysregulation of the Notch and Ikaros signaling pathways, BCR-ABL translocation, redox, and inflammatory factors. This study demonstrated that biotherapeutic agents target aberrant molecular axis in CML-BC cells. The HALOA complex was synthesized by simple mixing of apo α-lactalbumin with oleic acid, which manages to inhibit BCR-ABL (b3a2 in K562 cells) translocation. It elevates the production of reactive oxygen species (ROS), reactive nitrogen species (RNS), and protein carbonyl, which induces DNA fragmentation in K562 cells but not in NIH cells. The complex manages to reduce the toxicity surrounding apoptotic cells by enhancing the production of superoxide dismutase (SOD) and the total antioxidant level. The HALOA complex increases leptin to maintain normoxic conditions, ultimately preventing angiogenesis. This complex downregulates the expression of IL-8 and MMP-9 and elevates the expression levels of Notch 4, Ikaros, and integrin alpha-D/CD-11d (tumor-suppressive), which conjointly prevents inflammation, metastasis, and epithelial-mesenchymal transition (EMT) in CML cells. Meanwhile, the complex downregulates Notch 1 and 2 (oncogenic), consequently inducing anoikis in CML cells. Overall, the HALOA complex shows credibility by targeting the combined molecular factors responsible for the pathogenesis of the disease and will also help to overcome MDR conditions in leukemia.
format Online
Article
Text
id pubmed-9262277
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-92622772022-07-08 The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis Singh, Vivek Singh, Ranjana Mahdi, Abbas Ali Tripathi, Anil Kumar J Med Life Original Article Blast crisis (BC) is an outcome that arises during the treatment process of chronic myeloid leukemia (CML), which is possibly attained by the dysregulation of the Notch and Ikaros signaling pathways, BCR-ABL translocation, redox, and inflammatory factors. This study demonstrated that biotherapeutic agents target aberrant molecular axis in CML-BC cells. The HALOA complex was synthesized by simple mixing of apo α-lactalbumin with oleic acid, which manages to inhibit BCR-ABL (b3a2 in K562 cells) translocation. It elevates the production of reactive oxygen species (ROS), reactive nitrogen species (RNS), and protein carbonyl, which induces DNA fragmentation in K562 cells but not in NIH cells. The complex manages to reduce the toxicity surrounding apoptotic cells by enhancing the production of superoxide dismutase (SOD) and the total antioxidant level. The HALOA complex increases leptin to maintain normoxic conditions, ultimately preventing angiogenesis. This complex downregulates the expression of IL-8 and MMP-9 and elevates the expression levels of Notch 4, Ikaros, and integrin alpha-D/CD-11d (tumor-suppressive), which conjointly prevents inflammation, metastasis, and epithelial-mesenchymal transition (EMT) in CML cells. Meanwhile, the complex downregulates Notch 1 and 2 (oncogenic), consequently inducing anoikis in CML cells. Overall, the HALOA complex shows credibility by targeting the combined molecular factors responsible for the pathogenesis of the disease and will also help to overcome MDR conditions in leukemia. Carol Davila University Press 2022-05 /pmc/articles/PMC9262277/ /pubmed/35815090 http://dx.doi.org/10.25122/jml-2021-0230 Text en © 2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Original Article
Singh, Vivek
Singh, Ranjana
Mahdi, Abbas Ali
Tripathi, Anil Kumar
The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
title The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
title_full The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
title_fullStr The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
title_full_unstemmed The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
title_short The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
title_sort bioengineered haloa complex induces anoikis in chronic myeloid leukemia cells by targeting the bcr-abl/notch/ikaros/redox/inflammation axis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262277/
https://www.ncbi.nlm.nih.gov/pubmed/35815090
http://dx.doi.org/10.25122/jml-2021-0230
work_keys_str_mv AT singhvivek thebioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT singhranjana thebioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT mahdiabbasali thebioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT tripathianilkumar thebioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT singhvivek bioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT singhranjana bioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT mahdiabbasali bioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis
AT tripathianilkumar bioengineeredhaloacomplexinducesanoikisinchronicmyeloidleukemiacellsbytargetingthebcrablnotchikarosredoxinflammationaxis